碎石設備市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年全球碎石設備市場規模達 16 億美元，預計 2025 年至 2034 年的複合年成長率將達到 6.3%。碎石設備已成為現代泌尿外科的重要工具，為分解腎臟、膀胱、胰臟和膽管中形成的結石提供了可靠的非侵入性解決方案。這些設備利用衝擊波和超音波等先進的能量源將結石碎成更小的碎片，從而實現自然排出或簡單去除。由於肥胖率上升、代謝紊亂和不良的飲食習慣，越來越多的人面臨腎結石和膽結石等泌尿系統疾病，對有效的結石管理解決方案的需求正在迅速成長。

患者對微創治療認知的不斷提高，加上碎石設備的技術進步，為市場擴張創造了有利條件。全球人口老化，由於糖尿病和高血壓等合併症，更容易形成結石，預計未來十年對這些設備的需求也將持續成長。醫療保健提供者擴大採用碎石技術，可提供精確、有針對性的治療，減少住院時間，從而帶來更好的患者治療效果。隨著醫院和專科診所尋求最大限度地降低手術風險並最佳化患者的康復期，向門診護理和非侵入性治療的持續轉變正在進一步推動市場向前發展。

市場主要分為體內碎石設備和體外震波碎石設備，兩者均可滿足各種臨床需求。 ESWL 設備在 2024 年創造了 8.418 億美元的產值，預計 2025 年至 2034 年的複合年成長率為 6.2%。由於這些設備無需手術切口即可從外部打碎結石，因此仍受到醫療保健提供者的高度青睞。 ESWL 手術的非侵入性降低了感染和併發症的風險，有助於患者更快康復，並提高了醫院和泌尿科中心對 ESWL 手術的接受度。 ESWL 的吸引力在於它能夠利用先進的成像技術提供高精度結石定位，最大限度地減少對周圍組織的損傷。

碎石設備用於治療各種類型的結石，包括位於腎臟、輸尿管、胰臟和膽管的結石，其中腎結石在 2024 年佔據 43.1% 的市場佔有率。預計到 2034 年，這一細分市場將達到 13 億美元，這主要是由於與缺水、不健康飲食和久坐不動的生活方式有關的腎結石病例日益增加。除了飲食和生活方式的影響外，遺傳傾向和可能導致結石形成的藥物的使用增加也增加了全球的病例數。

預計到 2034 年，僅美國碎石設備市場就將創造 11 億美元的產值，這得益於將卓越療效與患者舒適度相結合的下一代碎石系統的採用。攜帶式、緊湊型碎石設備的引入，可以快速設置和治療，再加上即時成像引導的進步，大大提高了門診和流動環境中執行的程序的效率。隨著美國醫療保健提供者優先考慮微創解決方案，對碎石設備的需求持續攀升，反映出以患者為中心的護理和改善臨床結果的更廣泛趨勢。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 泌尿系統結石盛行率不斷上升
    • 碎石設備的技術進步
    • 老年人口不斷增加
    • 大眾對腎結石的認知提高
  • 產業陷阱與挑戰
    • 碎石術相關併發症
    • 去除結石的替代治療方法
• 成長潛力分析
• 監管格局
• 技術格局
• 未來市場趨勢
• 差距分析
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第5章：市場估計與預測：按設備類型，2021 年至 2034 年

• 主要趨勢
• 體外震波碎石裝置
• 體內碎石裝置
  • 雷射碎石裝置
  • 電液碎石裝置
  • 超音波碎石裝置
  • 機械式碎石裝置

第6章：市場估計與預測：按應用，2021 年至 2034 年

• 主要趨勢
• 腎結石
• 輸尿管結石
• 胰臟結石
• 膽管結石

第7章：市場估計與預測：依最終用途，2021 年至 2034 年

• 主要趨勢
• 醫院
• 門診手術中心
• 其他最終用途

第8章：市場估計與預測：按地區，2021 年至 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 沙烏地阿拉伯
  • 南非
  • 阿拉伯聯合大公國

第9章：公司簡介

• Becton, Dickinson and Company
• Boston Scientific
• Cook Medical
• DirexGroup
• Dornier MedTech
• EDAP TMS
• ELMED Medical Systems
• EMS
• Inceler Medikal
• Medispec
• MTS Medical
• Olympus
• Richard Wolf
• Siemens Healthineers
• STORZ MEDICAL

The Global Lithotripsy Devices Market generated USD 1.6 billion in 2024 and is poised to grow at a CAGR of 6.3% from 2025 to 2034. Lithotripsy devices have emerged as vital tools in modern urology, offering a reliable, non-invasive solution to break down stones that form in the kidneys, bladder, pancreas, and bile ducts. These devices utilize advanced energy sources such as shock waves and ultrasound to fragment stones into smaller pieces, enabling natural expulsion or simple removal. As more people face urological conditions like kidney stones and gallstones, primarily due to rising obesity rates, metabolic disorders, and poor dietary habits, the demand for efficient stone management solutions is rapidly growing.

Increasing awareness among patients about minimally invasive treatments, coupled with technological advancements in lithotripsy devices, is creating favorable conditions for market expansion. The aging global population, which is more susceptible to stone formation due to comorbidities like diabetes and hypertension, is also expected to drive consistent demand for these devices over the next decade. Healthcare providers are increasingly adopting lithotripsy technologies that offer precise, targeted treatment with reduced hospitalization time, leading to better patient outcomes. The ongoing shift toward outpatient care and non-invasive therapies is further propelling the market forward as hospitals and specialty clinics seek to minimize procedural risks and optimize recovery periods for patients.

The market is primarily segmented into intracorporeal lithotripsy devices and extracorporeal shock wave lithotripsy devices, both of which cater to various clinical needs. ESWL devices generated USD 841.8 million in 2024 and are projected to grow at a CAGR of 6.2% from 2025 to 2034. These devices remain highly preferred among healthcare providers due to their ability to break stones externally without surgical incisions. The non-invasive nature of ESWL procedures reduces the risk of infections and complications, supporting faster patient recovery and increasing their acceptance across hospitals and urology centers. ESWL's appeal lies in its ability to provide high-precision stone targeting using advanced imaging technologies, minimizing damage to surrounding tissues.

Lithotripsy devices are used to treat various types of stones, including those located in the kidneys, ureters, pancreas, and bile ducts, with kidney stones accounting for a 43.1% market share in 2024. This segment is projected to reach USD 1.3 billion by 2034, driven by the growing prevalence of kidney stone cases linked to poor hydration, unhealthy diets, and sedentary lifestyles. In addition to dietary and lifestyle influences, genetic predisposition and the increased use of medications that may lead to stone formation are adding to the caseload worldwide.

The U.S. Lithotripsy Devices Market alone is expected to generate USD 1.1 billion by 2034, fueled by the adoption of next-generation lithotripsy systems that combine superior efficacy with patient comfort. The introduction of portable and compact lithotripsy devices that allow for quick setup and treatment, coupled with advancements in real-time imaging guidance, has significantly enhanced the efficiency of procedures performed in outpatient and ambulatory settings. As healthcare providers in the U.S. prioritize minimally invasive solutions, the demand for lithotripsy devices continues to climb, reflecting a broader trend toward patient-centric care and improved clinical outcomes.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of urolithiasis
    • 3.2.1.2 Technological advancements in lithotripsy devices
    • 3.2.1.3 Growing geriatric population
    • 3.2.1.4 Rise in public awareness about kidney stones
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Complications associated with lithotripsy
    • 3.2.2.2 Availability of alternative treatments for stone removal
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Extracorporeal shock wave lithotripsy devices
• 5.3 Intracorporeal lithotripsy devices
  • 5.3.1 Laser lithotripsy devices
  • 5.3.2 Electrohydraulic lithotripsy devices
  • 5.3.3 Ultrasonic lithotripsy devices
  • 5.3.4 Mechanical lithotripsy devices

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Kidney stones
• 6.3 Ureteral stones
• 6.4 Pancreatic stones
• 6.5 Bile duct stones

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Becton, Dickinson and Company
• 9.2 Boston Scientific
• 9.3 Cook Medical
• 9.4 DirexGroup
• 9.5 Dornier MedTech
• 9.6 EDAP TMS
• 9.7 ELMED Medical Systems
• 9.8 EMS
• 9.9 Inceler Medikal
• 9.10 Medispec
• 9.11 MTS Medical
• 9.12 Olympus
• 9.13 Richard Wolf
• 9.14 Siemens Healthineers
• 9.15 STORZ MEDICAL